Last reviewed · How we verify
Standard group
At a glance
| Generic name | Standard group |
|---|---|
| Also known as | Ultrasound examination, Placebo, adrenaline, epinephrine, Conventional dose, Perivascular vasopresssin |
| Sponsor | University of Sao Paulo General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- Immediate Restoration of a New Implant With High Primary Stability (NA)
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- Inhaled Ciclesonide Study in Preterm Infants (PHASE1)
- Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients" (NA)
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- A Self-management Program to Prevent Falls in People With Multiple Sclerosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard group CI brief — competitive landscape report
- Standard group updates RSS · CI watch RSS
- University of Sao Paulo General Hospital portfolio CI